Records containing: Hepatitis C
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-12-29An Exercise Intervention to Prevent Interferon-Induced Depression in Hepatitis C
-
CLINICAL_TRIALS study record update · 2016-12-29A Randomized, Multicenter, Open Label Study Evaluating the Efficacy and Safety of Tailored Regimens With Peginterferon Alfa-2a Plus Ribavirin According Viral Kinetics for Genotype 1 Chronic Hepatitis C Patients
-
CLINICAL_TRIALS study record update · 2016-12-15The Phase 1a/1b Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients
-
CLINICAL_TRIALS study record update · 2016-12-14ClinicalTrials.gov study NCT02992184
-
CLINICAL_TRIALS study record update · 2016-12-13Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests As a Tool for Screening and Access to Care Among At-Risk Populations
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-12-12Unraveling the Mechanisms of Non-Response in Patients With and Without Cirrhosis Due to Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2016-12-08A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
-
CLINICAL_TRIALS study record update · 2016-11-30A Phase I,II Open-Label Dose Escalation Study to Evaluate the Safety and Efficacy of Single Doses of TT-034 for Subjects With Chronic Hepatitis C (CHC) Infection
-
CLINICAL_TRIALS study record update · 2016-11-29Interferon Alfa Sensitivity in HIV/HCV Coinfected Persons Before and After Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2016-11-21A Multi-centre Single-arm Study to Evaluate the Efficacy and Safety of BOCEPREVIR 44 Weeks in Addition to Standard of Care (SOC) in Previously Treatment Failure (Relapser, Non-responders, Both Partial and Null) Patients With Chronic Hepatitis C Genotype 1 (G1) and Cirrhosis (F4 Metavir). (MK-3034-105)
-
CLINICAL_TRIALS study record update · 2016-11-17A Phase II Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172, MK-8742, and Sofosbuvir in Treatment-Naïve Subjects With Chronic HCV GT1 or GT3 Infection
-
CLINICAL_TRIALS study record update · 2016-11-15Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling
-
CLINICAL_TRIALS study record update · 2016-10-27Effectiveness and Tolerability of Hepatitis C Treatment in HIV Co-infected Patients in Routine Care Services in Asia: A Pilot Model of Care Project
-
CLINICAL_TRIALS study record update · 2016-10-26Can Vitamin D Supplementation Improve Hepatitis C Cure Rates : A Pilot Multicentre Randomised Controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2016-10-25Relation Between Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life
-
CLINICAL_TRIALS study record update · 2016-10-21DVD-based HIV/HCV Intervention for Drug-Involved Latino Criminal Justice Clients
-
CLINICAL_TRIALS study record update · 2016-10-14A Phase 2a, Partly Randomized, Open-label Trial to Investigate the Efficacy and Safety of an 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Subjects With Chronic Genotype 4 Hepatitis C Infection
-
CLINICAL_TRIALS study record update · 2016-10-13A Multicenter, Open-label, Randomized, 2-arm, Phase II Trial of Pharmacodynamics, Pharmacokinetics and Safety of Two Dose Regimens of DEB025/Alisporivir in Combination With Ribavirin Therapy in Chronic Hepatitis C Genotype 2 and 3 Patients Who Have Previously Failed Interferon Therapy or Are Intolerant or Unable to Take Interferon.
-
CLINICAL_TRIALS study record update · 2016-10-11A Phase II, Randomized Clinical Trial to Study the Safety, Tolerability, and Efficacy of the Combination Regimen of MK-5172 and MK-8742 in Japanese Subjects With Chronic Hepatitis C and a Phase III, Randomized Placebo-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of the Combination Regimen of MK-5172 and MK-8742 in Japanese Subjects With Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2016-09-30A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of DEB025/Alisporivir in Combination With Peg-IFNα2a and Ribavirin in Hepatitis C Genotype 1 Treatment-naïve Patients
-
CLINICAL_TRIALS study record update · 2016-09-29Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis
-
CLINICAL_TRIALS study record update · 2016-09-28Implementation of a Sexual Health Intervention for YMSM in Two Vietnamese Cities
-
CLINICAL_TRIALS study record update · 2016-09-21Prospective Monitoring of Immune Parameters in Patients With Hepatitis C Under Treatment With Direct Acting Antivirals
-
CLINICAL_TRIALS study record update · 2016-09-21A Randomized Prospective Open Label Study of Switching to Raltegravir Based ART Compared to Maintaining Ritonavir Boosted PI-based ART on Liver Fibrosis Progression in HIV-HCV Coinfected Patients
-
CLINICAL_TRIALS study record update · 2016-09-16A Phase 2, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir + GS-5816 for 12 Weeks in Treatment-Experienced Subjects With Chronic HCV Infection